Humoral Innate Immunity and Acute-Phase Proteins
Comprehensive Overview
This review, published in the New England Journal of Medicine (2023), examines a group of blood proteins that the body rapidly produces during inflammation, known as acute-phase proteins, and their role in a lesser-known branch of the immune system called humoral innate immunity, which acts as the body's first, broad-spectrum line of defense before more specific antibody responses develop. The most familiar of these, C-reactive protein, was first identified nearly a century ago and is still widely used today to help diagnose infection and other illness, but researchers now understand many more of these molecules and how they work together. When the body detects infection, tissue injury, or other danger signals, it triggers a cascade of chemical messengers that prompts the liver and other tissues to rapidly ramp up production of dozens of these proteins, which help the body recognize and neutralize threats, activate a defensive cascade called the complement system, and support tissue repair. The authors review how these proteins are produced, how they function, and how measuring them in blood has become an essential diagnostic and prognostic tool across a wide range of conditions, including infection, heart disease, cancer, and, most recently, Covid-19.
Outcomes and Implications
The most notable takeaway from this review is that acute-phase proteins have proven especially valuable during the Covid-19 pandemic, where measuring several of them together helped clinicians identify which patients were likely to become critically ill. C-reactive protein levels correlated with a greater likelihood of death, intensive care admission, and the need for certain immune-suppressing treatments, while elevated ferritin was linked to a higher chance of requiring mechanical ventilation, and a related protein called D-dimer signaled increased risk of dangerous blood clots. One protein, pentraxin 3, emerged as a particularly strong independent predictor of death within 28 days of hospitalization, appearing to outperform several other, more familiar markers. These proteins also carried signals relevant to long Covid, a condition marked by persistent fatigue and other lingering symptoms, suggesting ongoing low-grade inflammation may help explain some cases. Beyond infection, the review highlights that acute-phase proteins are involved in wound healing, blood clotting, and iron regulation, and abnormal levels have been tied to cardiovascular disease, cancer, and neurodegenerative conditions. This matters because these are inexpensive, widely available blood tests that could be combined with newer, more sophisticated molecular profiling techniques to build more accurate, personalized tools for predicting a patient's disease course. The authors conclude that a century after the discovery of C-reactive protein, acute-phase proteins remain far more than passive markers of illness, and that better integrating them into modern diagnostic and therapeutic strategies holds real promise for improving patient care.